WW International Inc

WW International Inc(WW)股票分析

$12.840

+0.751 (+5.85%)收盘时

Loading chart…
最高
14.490
开盘
14.490
成交量加权均价
12.80
成交量
610.77K
市值
95.05M
最低
11.080
成交额
7.82M
企业价值/息税折旧摊销前利润(TTM)
2.90

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.

AI 分析 of WW International Inc (WW)

持有

WW International Inc is currently not a strong buy due to its low RSI of 38.49, indicating potential oversold conditions, and a significant year-to-date decline of 57.41%. The stock is trading at $13.39, well below its 52-week high of $38.38, suggesting room for recovery but also highlighting the risks involved.

估值指标

WW International Inc(WW)当前预期市盈率为 74.07,5 年平均预期市盈率为 -2.32。

预期市盈率

合理
5 年均值 P/E
-2.32
当前P/E
74.07
高估
153.90
低估
-158.53

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
9.09
当前EV/EBITDA
2.90
高估
17.52
低估
0.65

预期市销率

合理
5 年均值 P/S
0.43
当前P/S
0.20
高估
0.87
低估
-0.02

持有 WW 的大户

C

Contrarius Investment Management Ltd.

+ 持有WW

+0.01%

3个月收益率

A

Aristeia Capital, LLC

+ 持有WW

-0.95%

3个月收益率

事件时间线

2026-11-05 (ET)

08:31:00

Weight Watchers Reports Q3 Revenue of $152.9M

08:30:00

Company Narrows FY26 EBITDA Outlook to $110M-$115M

2026-09-29 (ET)

08:30:00

WW International Partners with Google Health Enterprise

2026-09-09 (ET)

09:00:00

WW Appoints Stephen Bye as New CEO

2026-08-05 (ET)

19:30:00

Company Adjusts FY26 EBITDA Outlook to $105M-$115M

资讯

WW 常见问题 —— 由 Alphio AI 解答

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools. It operates in the Consumer Non-Cyclicals sector (SERVICES-PERSONAL SERVICES industry).

WW International Inc is currently not a strong buy due to its low RSI of 38.49, indicating potential oversold conditions, and a significant year-to-date decline of 57.41%. The stock is trading at $13.39, well below its 52-week high of $38.38, suggesting room for recovery but also highlighting the risks involved.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易